Morgan Stanley lowered the firm’s price target on Accenture to $325 from $340 and keeps an Overweight rating on the shares as the firm is "tactically cautious" ahead of next week’s quarterly report given how macroeconomic conditions have worsened since December. Investors are "acutely focused" on the FY23 outlook and macroeconomic uncertainty should be "increasingly apparent this quarter," said the firm, which sees management navigating what it believes is a softer demand environment.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ACN:
- Accenture, Telus partner on entertainment, personalized digital life platform
- Accenture wins five-year $628M recompete of a contract award from CMS
- Accenture Ventures makes strategic investment in AI company Ocean Genomics
- IBM sues former Thai executive for $470,000 in bonus awards, Bloomberg reports
- Accenture acquires Morphus, terms not disclosed